base solidifi focu turn
solidifi base focu turn june analyst day turn
upsid low expect virtual segment outperform initi
guidanc attent turn june analyst day expect
provid near long-term target busi possibl view toward
provid call addit compani provid detail
new servic compani bring market target cash flow
debt quit import given elev balanc sheet leverag post
aetna meantim continu monitor pbm sell season gross
win off-set below-averag mid retent rate thu far beyond overal
headlin target look see whether underli retail pbm
busi return growth given variou headwind impact
busi per model pbm segment ebit declin
adjust eps/pt follow today upsid rais ep estim
larg back strong result aetna busi
term cadenc manag reiter expect retail pbm
busi see improv oper incom growth throughout year
hcb aetna segment expect see greatest level oper incom
lowest howev trim ep
take conserv stanc pbm busi follow today disclosur
sell season known health plan custom loss leav
segment larg unchang still assum buyback expect pbm
weak somewhat off-set deal synergi track
expect brand new modern program expect yield
bln run-rat net save slightli conserv ep
trim pt base price-to-earnings multipl lower
ep
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
lower usd
return equiti ttm
link barclay live interact chart
overweight combin aetna set
compani path off-set slower-growth
retail pbm busi fast-grow aetna
busi expect acceler growth
establish key healthcar partner
upsid case see better expect synergi
cross sell product improv medic loss
ratio combin retail pbm
posit trend compani retail/pbm
busi would lead multipl expans
downsid case see slower expect
synergi aetna transact misstep
handl insur portion busi
coupl continu loss retail/pbm
busi lead multipl contraciton
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
 guidanc outlookenterpris segment outlook retail milretail/ltc ebit servic servic lsd lsd benefit outlook year end medic mlnadjust /- /- bpshcb commerci medic /- /- bpscorpor segment mlnother itemsinterest mlntax mlnnet mlnincrement invest mlnpss mlnrss mlnhcb mlncash retail/ltcstrong script growth pharmacystrong script growth pharmacyannu tax reform invest ltcannual tax reform invest ltccontribut half segment contractioncontribut half segment contractioncontinu reimburs pressurecontinu reimburs pressuref expect drive marginf expect drive marginnot pbmprice compress worsen low brand inflationpr compress worsen low brand inflationbenefit sell season modestbenefit sell season modestanthem strong headwind due acceler timelineanthem strong headwind due acceler timelineanthem revenu record net basisanthem revenu record net basisaetna mail order specialti pbmaetna mail order specialti pbmnote hcbyr deal synergi benefit hcb mostyr deal synergi benefit hcb mostincrement invest acceler growthincrement invest acceler growthsuspens hif impact certain op ratiossuspens hif impact certain op ratioscertain one-tim benefit repeat one-tim benefit repeat segment shift invest hif op incom growexcl segment shift invest hif op incom growmodestli enterpriseseason result resembl result resembl pbm see greatest y/i deterior pbm see greatest y/i deterior op incom greatest lowest op incom greatest lowest barclay
 annual segment analysi mln
segment product revenueactualprojectedprojectedprojectedconsolid invest chang consolid invest gross oper synergi adj oper incomepss formerli oper chang oper incomepss formerli oper barclay
 annual incom statement invest product sold ex one-tim expens ex one-tim addback expens pre-tax rate minor interest/earn net ep fulli combin co ep dilut share line growth expens ex one-tim pre-tax net per barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
